-
公开(公告)号:US20220380347A1
公开(公告)日:2022-12-01
申请号:US17247000
申请日:2021-05-03
发明人: Lee D. Arnold , Uri Lopatin , Walter Keung
IPC分类号: C07D403/12 , C07D401/12 , C07D401/14 , A61K45/06
摘要: The disclosure provides compounds with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US20240270721A1
公开(公告)日:2024-08-15
申请号:US18461179
申请日:2023-09-05
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D403/12 , C07D207/26 , C07D401/12 , C07D401/14 , C07D403/14 , C07D417/14 , C07D471/04
CPC分类号: C07D403/12 , C07D207/26 , C07D401/12 , C07D401/14 , C07D403/14 , C07D417/14 , C07D471/04
摘要: The disclosure provides compounds, such as compounds of Formula II, with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US11124497B1
公开(公告)日:2021-09-21
申请号:US17230727
申请日:2021-04-14
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D207/26 , C07D471/04 , C07D417/14
摘要: The disclosure provides compounds with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease. Exemplary compounds provided include Formula II-I, where R3, RB are provided herein:
-
公开(公告)号:US20240277795A1
公开(公告)日:2024-08-22
申请号:US18444009
申请日:2024-02-16
CPC分类号: A61K38/05 , A61K45/06 , A61P31/14 , C07K1/1077
摘要: The disclosure provides compounds with nitrile warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with nitrile warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US20240208933A1
公开(公告)日:2024-06-27
申请号:US18589700
申请日:2024-02-28
发明人: Ruiping Wang , Meiting Shi , Arnold D. Lee , David J. Turnquist
IPC分类号: C07D401/12 , A61K31/454 , A61K45/06
CPC分类号: C07D401/12 , A61K31/454 , A61K45/06
摘要: The disclosure is in part directed to crystalline forms of 7-chloro-N—((S)-1-(((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-1H-indole-2-carboxamide and pharmaceutical compositions thereof.
-
公开(公告)号:US20230192663A1
公开(公告)日:2023-06-22
申请号:US18168803
申请日:2023-02-14
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D403/12 , C07D401/12 , C07D207/26 , C07D417/14 , C07D403/14 , C07D471/04 , C07D401/14
CPC分类号: C07D403/12 , C07D401/12 , C07D207/26 , C07D417/14 , C07D403/14 , C07D471/04 , C07D401/14
摘要: The disclosure provides compounds, such as compounds of Formula II, with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US20240270693A1
公开(公告)日:2024-08-15
申请号:US17828881
申请日:2022-05-31
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D213/90 , A61K45/06
CPC分类号: C07D213/90 , A61K45/06
摘要: The disclosure provides compounds with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US20230212152A1
公开(公告)日:2023-07-06
申请号:US18008914
申请日:2021-06-09
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D403/12 , C07D207/267 , C07D417/14 , C07D209/42 , C07D471/04 , C07D405/14 , C07D403/14 , C07D401/14 , C07D471/10 , C07D401/12 , C07D417/12 , C07D487/10 , C07D209/52 , C07D209/44 , C07D209/56 , C07D413/14 , C07D491/107 , C07D513/04 , C07D491/18 , C07F7/08 , C07D207/34 , C07D221/20 , C07D209/54 , A61P31/14 , A61K47/64 , A61K45/06 , C12N9/50
CPC分类号: C07D403/12 , C07D207/267 , C07D417/14 , C07D209/42 , C07D471/04 , C07D405/14 , C07D403/14 , C07D401/14 , C07D471/10 , C07D401/12 , C07D417/12 , C07D487/10 , C07D209/52 , C07D209/44 , C07D209/56 , C07D413/14 , C07D491/107 , C07D513/04 , C07D491/18 , C07F7/0812 , C07F7/0816 , C07D207/34 , C07D221/20 , C07D209/54 , A61P31/14 , A61K47/64 , A61K45/06 , C12N9/506 , C12Y304/22066
摘要: The disclosure provides compounds of formula II with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US20220402896A1
公开(公告)日:2022-12-22
申请号:US17859827
申请日:2022-07-07
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D403/12 , C07D207/26 , C07D471/04 , C07D401/12 , C07D403/14 , C07D401/14 , C07D417/14
摘要: The disclosure provides compounds, such as compounds of Formula II, with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
公开(公告)号:US20220324844A1
公开(公告)日:2022-10-13
申请号:US17841172
申请日:2022-06-15
发明人: Lee D. Arnold , Andy Jennings , Walter Keung
IPC分类号: C07D403/12 , C07D207/26 , C07D471/04 , C07D401/12 , C07D403/14 , C07D401/14 , C07D417/14
摘要: The disclosure provides compounds, such as compounds of Formula II, with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
-
-
-
-
-
-
-
-
-